Muutke küpsiste eelistusi

E-raamat: Cerebral Hemorrhage

Edited by , Edited by , Edited by , Edited by , Edited by , Edited by , Edited by , Edited by
  • Formaat - PDF+DRM
  • Hind: 221,68 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Cerebral hemorrhage is a common and often fatal subtype of stroke. while in the past it has received relatively little attention compared to ischemic stroke, there have been major advances in our understanding of this devastating form of stroke. The papers by world experts cover the field from molecular biology to clinical trials.
Experimental intracerebral hemorrhage iron, hemoglobin and free
radicals.- Deferoxamine therapy for intracerebral hemorrhage.- Bilirubin
oxidation products, oxidative stress, and intracerebral hemorrhage.-
Deferoxamine reduces brain swelling in a rat model of hippocampal
intracerebral hemorrhage.- The antioxidant effects of melatonin after
intracerebral hemorrhage in rats.- Poly(ADP-ribose) polymerase activation and
brain edema formation by hemoglobin after intracerebral hemorrhage in rats.-
Induction of autophagy in rat hippocampus and cultured neurons by iron.-
Effects of superoxide dismutase and catalase derivates on intracerebral
hemorrhage-induced brain injury in rats.- Metallothionein and brain injury
after intracerebral hemorrhage.- Experimental intracerebral hemorrhage
inflammation and thrombin.- Intracerebral hemorrhage injury mechanisms:
glutamate neurotoxicity, thrombin, and Src.- Increase in brain thrombin
activity after experimental intracerebral hemorrhage.- Microglial activation
and intracerebral hemorrhage.- Concomitant intracerebral infusion of tissue
plasminogen activator and thrombin leads to brain injury.- Microglial
activation and brain injury after intracerebral hemorrhage.- Effects of aging
on complement activation and neutrophil infiltration after intracerebral
hemorrhage.- Experimental intracerebral hemorrhage other mechanisms.-
Blood-brain barrier function in intracerebral hemorrhage.- Treatment of
stroke and intracerebral hemorrhage with cellular and pharmacological
restorative therapies.- Deficiency of CD18 gene reduces brain edema in
experimental intracerebral hemorrhage in mice.- Tissue inhibitor of matrix
metalloproteinases-3 (TIMP-3) lacks involvement in bacterial
collagenase-induced intracerebral hemorrhage in mouse.- Radialglia marker
expression following experimental intracerebral hemorrhage.- Long-term
effects of melatonin after intracerebral hemorrhage in rats.- Management of
delayed edema formation after fibrinolytic therapy for intracerebral
hematomas: preliminary experimental data.- Erythropoietin attenuates
intracerebral hemorrhage by diminishing matrix metalloproteinases and
maintaining blood-brain barrier integrity in mice.- Hyperbaric oxygen for
experimental intracerebral hemorrhage.- Effect of amantadine sulphate on
intracerebral hemorrhage-induced brain injury in rats.- Experimental
intracerebral hemorrhage model development and characterization.- Long-term
behavioral characterization of a rat model of intracerebral hemorrhage.-
Neurological deficits and brain edema after intracerebral hemorrhage in
Mongolian gerbils.- Rat model of intracerebellar hemorrhage.- A rat model of
pontine hemorrhage.- Human intracerebral hemorrhage.- The optimal time-window
for surgical treatment of spontaneous intracerebral hemorrhage: result of
prospective randomized controlled trial of 500 cases.- Preliminary findings
of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage
evacuation (MISTIE) clinical trial.- Pediatric cerebrovascular diseases:
report of 204 cases.- Xenon-CT study of regional cerebral blood flow around
hematoma in patients with basal ganglia hemorrhage.- Preliminary application
of pyramidal tractography in evaluating prognosis of patients with
hypertensive intracerebral hemorrhage.- Experimental intracranial hemorrhage
(non-intracerebral hemorrhage).- Mechanisms and markers for hemorrhagic
transformation after stroke.- The clinical significance of acute brain injury
in subarachnoid hemorrhage and opportunity for intervention.- Development of
a cerebralmicrovascular dysplasia model in rodents.- Hyperbaric oxygen
preconditioning protects against traumatic brain injury at high altitude.-
Human intracranial hemorrhage (non-intracerebral hemorrhage).- Genetic
considerations relevant to intracranial hemorrhage and brain arteriovenous
malformations.- Vasospasm after aneurysmal subarachnoid hemorrhage: need for
further study.- Regional cerebral blood flow and oxygen metabolism in
aneurysmal subarachnoid hemorrhage: positron emission tomography evaluation
of clipping versus coiling.- Preliminary report of the clot lysis evaluating
accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical
trial.- Leptin plays a role in ruptured human brain arteriovenous
malformations.- Novel treatments for cerebral vasospasm following aneurysmal
subarachnoid hemorrhage.- Relationship between serum sodium level and brain
ventricle size after aneurysmal subarachnoid hemorrhage.- Lack of association
between apolipoprotein E promoters in 4? carriers and worsening on computed
tomography in early stage of traumatic brain injury.